123 related articles for article (PubMed ID: 26392387)
1. Illness Perception in Primary Cutaneous T-cell Lymphomas: What Patients Believe About Their Disease.
Eder J; Kammerstätter M; Erhart F; Mairhofer-Muri D; Trautinger F
Acta Derm Venereol; 2016 Mar; 96(3):381-5. PubMed ID: 26392387
[TBL] [Abstract][Full Text] [Related]
2. Patients' Illness Perception as a Tool to Improve Individual Disease Management in Primary Cutaneous Lymphomas.
Porkert S; Lehner-Baumgartner E; Valencak J; Knobler R; Riedl E; Jonak C
Acta Derm Venereol; 2018 Feb; 98(2):240-245. PubMed ID: 29048099
[TBL] [Abstract][Full Text] [Related]
3. Health-related quality-of-life assessment in patients with cutaneous T-cell lymphoma.
Demierre MF; Tien A; Miller D
Arch Dermatol; 2005 Mar; 141(3):325-30. PubMed ID: 15781673
[TBL] [Abstract][Full Text] [Related]
4. 'We had to change to single beds because I itch in the night': a qualitative study of the experiences, attitudes and approaches to coping of patients with cutaneous T-cell lymphoma.
Beynon T; Selman L; Radcliffe E; Whittaker S; Child F; Orlowska D; Morgans C; Morris S; Harding R
Br J Dermatol; 2015 Jul; 173(1):83-92. PubMed ID: 25688924
[TBL] [Abstract][Full Text] [Related]
5. Significant impact of cutaneous T-cell lymphoma on patients' quality of life: results of a 2005 National Cutaneous Lymphoma Foundation Survey.
Demierre MF; Gan S; Jones J; Miller DR
Cancer; 2006 Nov; 107(10):2504-11. PubMed ID: 17048251
[TBL] [Abstract][Full Text] [Related]
6. 'We're all carrying a burden that we're not sharing': a qualitative study of the impact of cutaneous T-cell lymphoma on the family.
Selman LE; Beynon T; Radcliffe E; Whittaker S; Orlowska D; Child F; Harding R
Br J Dermatol; 2015 Jun; 172(6):1581-1592. PubMed ID: 25546238
[TBL] [Abstract][Full Text] [Related]
7. 'It's a traumatic illness, traumatic to witness': a qualitative study of the experiences of bereaved family caregivers of patients with cutaneous T-cell lymphoma.
Orlowska D; Selman LE; Beynon T; Radcliffe E; Whittaker S; Child F; Harding R
Br J Dermatol; 2018 Oct; 179(4):882-888. PubMed ID: 29451670
[TBL] [Abstract][Full Text] [Related]
8. Illness perception in patients with differentiated epithelial cell thyroid cancer.
Hirsch D; Ginat M; Levy S; Benbassat C; Weinstein R; Tsvetov G; Singer J; Shraga-Slutzky I; Grozinski-Glasberg S; Mansiterski Y; Shimon I; Reicher-Atir R
Thyroid; 2009 May; 19(5):459-65. PubMed ID: 19415995
[TBL] [Abstract][Full Text] [Related]
9. Controversies in the management of the cutaneous T cell lymphomas.
Zic JA
Dermatol Ther; 2009; 22(5):407-17. PubMed ID: 19845718
[TBL] [Abstract][Full Text] [Related]
10. Illness perceptions and coping determine quality of life in COPD patients.
Tiemensma J; Gaab E; Voorhaar M; Asijee G; Kaptein AA
Int J Chron Obstruct Pulmon Dis; 2016; 11():2001-7. PubMed ID: 27601893
[TBL] [Abstract][Full Text] [Related]
11. High expression of Dicer reveals a negative prognostic influence in certain subtypes of primary cutaneous T cell lymphomas.
Valencak J; Schmid K; Trautinger F; Wallnöfer W; Muellauer L; Soleiman A; Knobler R; Haitel A; Pehamberger H; Raderer M
J Dermatol Sci; 2011 Dec; 64(3):185-90. PubMed ID: 21937200
[TBL] [Abstract][Full Text] [Related]
12. [Malignant lymphoma of the skin].
Burg G; Dommann S; Dummer R
Ther Umsch; 1993 Dec; 50(12):828-34. PubMed ID: 8171405
[TBL] [Abstract][Full Text] [Related]
13. [Management of cutaneous T-cell lymphomas: Recommendations of the French Cutaneous Lymphoma Group].
Beylot-Barry M; Dereure O; Vergier B; Barete S; Laroche L; Machet L; Delfau-Larue MH; D'Incan M; Grange F; Ortonne N; Merlio JP; Bagot M;
Ann Dermatol Venereol; 2010 Oct; 137(10):611-21. PubMed ID: 20932440
[TBL] [Abstract][Full Text] [Related]
14. Cutaneous T-cell lymphoma: a case study, treatment, and nursing implications.
Harris JS; Macey WH
Dermatol Nurs; 1994 Feb; 6(1):41-9. PubMed ID: 7946828
[TBL] [Abstract][Full Text] [Related]
15. Cutaneous T-cell lymphoma: overview and nursing perspectives.
McCann SA
Nurs Clin North Am; 2007 Sep; 42(3):421-55, vi-vii. PubMed ID: 17825663
[TBL] [Abstract][Full Text] [Related]
16. CD56-positive haematological neoplasms of the skin: a multicentre study of the Cutaneous Lymphoma Project Group of the European Organisation for Research and Treatment of Cancer.
Assaf C; Gellrich S; Whittaker S; Robson A; Cerroni L; Massone C; Kerl H; Rose C; Chott A; Chimenti S; Hallermann C; Petrella T; Wechsler J; Bagot M; Hummel M; Bullani-Kerl K; Bekkenk MW; Kempf W; Meijer CJ; Willemze R; Sterry W
J Clin Pathol; 2007 Sep; 60(9):981-9. PubMed ID: 17018683
[TBL] [Abstract][Full Text] [Related]
17. Cutaneous T-cell lymphomas (including rare subtypes). Current concepts. II.
Paulli M; Berti E
Haematologica; 2004 Nov; 89(11):1372-88. PubMed ID: 15531460
[TBL] [Abstract][Full Text] [Related]
18. Cutaneous T-cell lymphoma: from genetics to clinical practice.
Dummer R; Zucca E
Oncology (Williston Park); 2007 Feb; 21(2 Suppl 1):7-8. PubMed ID: 17474352
[No Abstract] [Full Text] [Related]
19. Measuring HRQOL in patients with cutaneous T-cell lymphoma undergoing therapy with oral bexarotene and extracorporeal photopheresis.
Demierre MF; Ferzli P; Miller D
Arch Dermatol; 2007 May; 143(5):659-61. PubMed ID: 17515522
[No Abstract] [Full Text] [Related]
20. The clinical and humanistic burden of cutaneous T-cell lymphomas and response to conventional and novel therapies: results of a systematic review.
Dalal M; Mitchell S; McCloskey C; Zagadailov E; Gautam A
Expert Rev Hematol; 2020 Apr; 13(4):405-419. PubMed ID: 31958235
[No Abstract] [Full Text] [Related]
[Next] [New Search]
